BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2523645)

  • 1. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD; Rüegg PC; Keller A; Waite R
    Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
    Simonsen K; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isradipine in essential hypertension: the Belgian General Practitioners' Study.
    De Keyser P; Bouvé J; Clement D; Degraef R; Meurant JP; Rorive G; Van Thillo J
    Am J Med; 1989 Apr; 86(4A):103-9. PubMed ID: 2565687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
    Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.